Literature DB >> 12769257

Differential expression of connexin43 in foetal, adult and tumour-associated human brain endothelial cells.

Mariella Errede1, Vincenzo Benagiano, Francesco Girolamo, Paolo Flace, Mirella Bertossi, Luisa Roncali, Daniela Virgintino.   

Abstract

Connexin43 (Cx43), the main protein constituting the gap junctions between astrocytes, has previously been demonstrated in endothelial cells of somatic vessels where the intercellular coupling that it provides plays a role in endothelial proliferation and migration. In this study, Cx43 expression was analysed in human brain microvascular endothelial cells of the cortical plate of 18-week foetal telencephalon, in adult cerebral cortex and glioma (astrocytomas). The study was carried out by immunocytochemistry utilizing a Cx43 monoclonal antibody and a polyclonal antibody anti-GLUT1 (glucose transporter isoform 1) to identify the endothelial cells and to localize Cx43. Endothelial Cx43 is differently expressed in the cortical plate, cerebral cortex and astrocytoma. Within the cortical plate and tumour, Cx43 is highly expressed in microvascular endothelial cells whereas it is virtually absent in the cerebral cortex microvessels. The high expression of the gap junction protein in developing brain, as well as in brain tumours, may be related to the growth status of the microvessels during brain and tumour angiogenesis. The lack of endothelial Cx43 in the cerebral cortex is in agreement with the characteristics of the mature brain endothelial cells that are sealed by tight junctions. In conclusion, the results indicate that endothelial Cx43 expression is developmentally regulated in the normal human brain and suggest that it is controlled by the microenvironment in both normal and tumour-related conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12769257     DOI: 10.1023/a:1023344106815

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  7 in total

Review 1.  Roles of gap junctions and connexins in non-neoplastic pathological processes in which cell proliferation is involved.

Authors:  Maria Lúcia Zaidan Dagli; Francisco Javier Hernandez-Blazquez
Journal:  J Membr Biol       Date:  2007-07-25       Impact factor: 1.843

Review 2.  Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.

Authors:  Juan A Orellana; Pablo J Sáez; Kenji F Shoji; Kurt A Schalper; Nicolás Palacios-Prado; Victoria Velarde; Christian Giaume; Michael V L Bennett; Juan C Sáez
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

3.  Resolving the transition from negative to positive blood oxygen level-dependent responses in the developing brain.

Authors:  Mariel G Kozberg; Brenda R Chen; Sarah E DeLeo; Matthew B Bouchard; Elizabeth M C Hillman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-20       Impact factor: 11.205

4.  Involvement of metalloprotease-2 in the development of human brain microvessels.

Authors:  Francesco Girolamo; Daniela Virgintino; Mariella Errede; Carmen Capobianco; Nunzia Bernardini; Mirella Bertossi; Luisa Roncali
Journal:  Histochem Cell Biol       Date:  2004-09-15       Impact factor: 4.304

5.  Targeted transport of 125I-labeled antibody to GFAP and AMVB1 in an experimental rat model of C6 glioma.

Authors:  Vladimir P Chekhonin; Vladimir P Baklaushev; Gaukhar M Yusubalieva; Olga I Gurina
Journal:  J Neuroimmune Pharmacol       Date:  2008-09-04       Impact factor: 4.147

6.  Development of the Neuro-Immune-Vascular Plexus in the Ventricular Zone of the Prenatal Rat Neocortex.

Authors:  Elisa Penna; Jon M Mangum; Hunter Shepherd; Veronica Martínez-Cerdeño; Stephen C Noctor
Journal:  Cereb Cortex       Date:  2021-03-05       Impact factor: 5.357

7.  The contribution of CXCL12-expressing radial glia cells to neuro-vascular patterning during human cerebral cortex development.

Authors:  Mariella Errede; Francesco Girolamo; Marco Rizzi; Mirella Bertossi; Luisa Roncali; Daniela Virgintino
Journal:  Front Neurosci       Date:  2014-10-15       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.